BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2019
View Archived Issues
Decreased inhibition, but no hyperexcitation, in multiple autism models
Read More
The Model T of CAR T cells?
Read More
Novo Nordisk initiates phase II study of NNC-0174-0833 for weight management
Read More
Serum CIRP as novel biomarker for monitoring disease activity in alopecia areata
Read More
Exosome therapy for hair loss shows promise
Read More
Eli Lilly studies LY-3375880 in phase II trial for moderate to severe atopic dermatitis
Read More
BARDA supports development of vaccine against Marburg virus infection
Read More
PPT1 inhibition through DC-661 compound shows antitumoral effects
Read More
SpringWorks Therapeutics initiates phase III study of nirogacestat
Read More
In gut, skin fungus may contribute to IBD
Read More
Tyme Technologies adds preclinical candidate to pipeline
Read More
Novel noninvasive rodent model of alopecia areata described
Read More
New variant of genetic mutation in the ANTXR2 gene found to be associated with hyaline fibromatosis
Read More
CBT-509 demonstrates promising efficacy in preclinical cancer models
Read More
Pirfenidone partially reverses severe pulmonary arterial hypertension in rat models
Read More
Novel tumor microenvironment system based on a 3D human co-culture with patient-derived tumor cells
Read More
GlaxoSmithKline and BioVersys divulge new antimycobacterials
Read More
Idorsia Pharmaceuticals discloses IDO1 and/or TDO inhibitors
Read More
Roche discloses metabotropic glutamate mGlu4 receptor PAMs
Read More
Agios Pharmaceuticals patents PKLR activators
Read More
European approval for Tecentriq with Avastin and chemotherapy for metastatic non-squamous NSCLC
Read More
Pfizer identifies TYK2 inhibitors
Read More
HOXC6 gene expression linked to cervical cancer progression
Read More
Helsinn opens phase III program with anamorelin to treat weight loss and anorexia in NSCLC cachexia
Read More